Benjamin Derman to Immunoglobulin Light-chain Amyloidosis
This is a "connection" page, showing publications Benjamin Derman has written about Immunoglobulin Light-chain Amyloidosis.
Connection Strength
0.442
-
Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias. Front Immunol. 2025; 16:1558275.
Score: 0.225
-
Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication. Oncologist. 2024 Sep 06; 29(9):806-810.
Score: 0.216